Storia in 1 fonti

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.

Raccontata da

forbes.com

Timeline cronologica

martedì 9 giugno 2026·forbes.com
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.